During these tough times, we continue to advocate for lung cancer patients and caregivers. This section is dedicated to policy endeavors related specifically to COVID-19 that LUNGevity is involved in. We have a separate public policy section where you can learn more about LUNGevity's other advocacy work in support of the lung cancer community.

Collaborative policy letters

LUNGevity works collaboratively with many other health-related organizations in submitting letters to federal lawmakers and regulatory agencies. This kind of input is critical in developing policies that improve patients' access to care and advancing innovation that will benefit people with lung cancer.

Here are some COVID-19-specific letters that LUNGevity has signed: